Showing results (101-110 of 169) with videos related to
Sort By:
Pageof 17
Toxics|January 8, 2025
Human Health Risk Assessment of Chlorinated Hydrocarbons in Groundwater Based on Multi-Pathway AnalysisYidi Wang, Guilan Li, Xiaohan Li, et al.Scientific Reports|October 10, 2023
Oblique lateral interbody fusion with internal fixations in the treatment for cross-segment degenerative lumbar spine disease (L2-3 and L4-5) finite element analysisShuyi Zhang, Yilong Zhang, Licai Huang, et al.Oncotarget|April 18, 2018
Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancerCheng Wei, Bowen Jin, Magdalena Szewczyk-Bieda, et al.Cancers|January 11, 2022
Predicting the Performance of Concurrent Systematic Random Biopsies during Image Fusion Targeted Sampling of Multi-Parametric MRI Detected Prostate Cancer. A Prospective Study (PRESET Study)Saeed Alqahtani, Xinyu Zhang, Cheng Wei, et al.Health and Quality of Life Outcomes|October 23, 2020
Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) in mainland China: an investigation of reliability, validity, and responsivenessFeifei Zhou, Shuyang Li, Yilong Zhang, et al.Cancers|December 24, 2021
Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate CancerChidozie N Ogbonnaya, Xinyu Zhang, Basim S O Alsaedi, et al.Statistics in Biopharmaceutical Research|May 23, 2022
Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data with Informative CensoringGuoqing Diao, Guanghan F Liu, Donglin Zeng, et al.Journal of Neurosurgery. Spine|July 18, 2020
Quantitative analysis of the correlation between preoperative cervical degeneration and postoperative heterotopic ossification after cervical disc replacement: minimum 10-year follow-up dataFeifei Zhou, Shuyang Li, Yanbin Zhao, et al.Cancer Chemotherapy and Pharmacology|March 15, 2006
High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2Yilong Zhang, Yousheng Hua, Doris M Benbrook, et al.Clinical Therapeutics|February 28, 2012
Tolerability and dose proportional pharmacokinetics of pasireotide administered as a single dose or two divided doses in healthy male volunteers: a single-center, open-label, ascending-dose studyStephan Petersenn, Ke Hu, Mario Maldonado, et al.Pageof 17